Unknown NA INTERVENTIONAL 3-arm NCT06193278

Individual Neuromodulation for PDS

Personalized Neuromodulation Treatment for Parkinson's Syndrome

Sponsor: Ruijin Hospital

Conditions Neuromodulation Parkinsonian Syndromes Transcranial Direct Current Stimulation Transcranial Magnetic Stimulation

Interventions Neuromodulation

Updated 4 times since 2024 Last updated: Jan 8, 2024 Started: Sep 1, 2023 Primary completion: May 31, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Neuromodulation and Parkinsonian Syndromes and is currently ongoing. Ruijin Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Oct 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruijin Hospital

Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China